Dr. Tesi has been President, Chief Executive Officer and acting Chief Medical Officer of INmune Bio since the formation of the Company in September 2015. Dr. Tesi has been at the leadership level of biotech companies, both public and private since, 1997. His industry experience has focused on translating the biology of immunology, chronic inflammation and immunosuppression as it applies to transplant, autoimmune disease, cancer, metabolic and neurodegenerative disease into the clinic including designing and executing clinical develop programs and product commercialization strategies. Prior to joining industry, Dr. Tesi was a clinically active academic transplant surgeon with experience in liver, pancreas, intestinal and kidney transplantation. Dr. Tesi received his MD degree from Washington University School of Medicine in 1982. Dr. Tesi has been a licensed physician and Fellow of the American College of Surgery.